Cdh5-2A-CreERT2
Nomenclature
C57BL/6Smoc-Cdh5em1(2A-CreERT2-WPRE-polyA)Smoc
Cat. NO.
NM-KI-200173
Strain State
Repository Live
Gene Summary
Gene Symbol
Cdh5
Model Description
Validation Data

Fig. 1 CreERT2-mediated recombination in the aorta of Cdh5CreERT2 /+; Rosa26tdTomato/+ mouse. TdTomato(red) expression can be detected in the arterial endothelial cells of Cdh5CreERT2 /+; Rosa26tdTomato/+ mouse after tamoxifen treatment.

Fig. 2 CreERT2-mediated recombination in the spinal cord of Cdh5CreERT2 /+; Rosa26tdTomato/+ mouse. TdTomato(red) expression can be detected in the endothelial cells derived from spinal cord of Cdh5CreERT2 /+; Rosa26tdTomato/+ mouse after tamoxifen treatment.

Fig. 3 CreERT2-mediated recombination in the cerebellum of Cdh5CreERT2 /+; Rosa26tdTomato/+ mouse. TdTomato(red) expression can be detected in some cells of cerebellum derived from Cdh5CreERT2 /+; Rosa26tdTomato/+ mouse after tamoxifen treatment.

Fig. 4 Detection of tdTomato(red) in various tissues of Cdh5CreERT2/+; Rosa26tdTomato/+ mice. CreERT2 mediated recombination can be detected in the brain, pituitary gland, eyes, heart, lung, liver, submandibular gland, kidney, pancreas, testis, muscle, intestine, colon, spleen, thymus and brown fat. TdTomato expression can not be observed in the epidermis. (For more detailed information please contact our technical advisor.)
You may also like
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreSMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
Learn more